Malaria News and Research

Latest Malaria News and Research

Yale University awarded $36 million ARRA funds for over 100 research projects

Faculty at Yale University have been awarded over 100 research grants totaling $36 million since February 2009, when the federal stimulus package was signed into law. Known as the American Recovery and Revitalization Act of 2009 (ARRA), the law aims to reinvigorate the economy and lay the foundation for long-term economic recovery by increasing investments in infrastructure, education, the environment and scientific research.

3 Sep 2009

Antibiotic used to treat trachoma reduces child mortality in Ethiopia, study finds

The antibiotic used to treat trachoma, "the world's leading preventable cause of blindness," may also protect children living in Ethiopia from death from of other diseases, according to a recent study, the Associated Press reports.

2 Sep 2009

World Climate Conference calls for global weather surveillance system, says could help predict disease outbreaks

The U.N. World Meteorological Organization (WMO) Monday opened the World Climate Conference - a week of talks in Geneva aimed at establishing a better global weather surveillance system to provide countries with "earlier, more accurate warnings about hurricanes, droughts and floods," the Associated Press reports.

2 Sep 2009

Eye disease medication lowers death rate among Ethiopian children

Children in Ethiopia who received the antibiotic azithromycin as a method for controlling the contagious eye disease trachoma had a lower odds of death compared to children who did not receive the antibiotic, according to a study in the September 2 issue of JAMA.

2 Sep 2009

Also in global health news: U.S. global development policy; DDT in Uganda; potential drought, famine in Ethiopia

"President Barack Obama has signed a Presidential Study Directive [PSD] authorizing a U.S. government-wide review of global development policy, according to sources briefed on the review by the White House," Foreign Policy's blog, "The Cable," reports. The new PSD is important, according to people in development, "because it signals the intent to reach across government agencies to think through a more coordinated and strategic approach to development policy," according to the blog (Rozen, 8/31).

2 Sep 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Zainab Akol, Uganda's AIDS Control Program director, said the health ministry has acquired enough antiretroviral (ARV) drugs to provide treatment for people living with HIV/AIDS until the end of the year, New Vision reports. In addition to 30 tons of drugs, the ministry received at the beginning of August from the Global Fund to Fight AIDS, Tuberculosis and Malaria, it also purchased ARVs worth about $20 million this month, Akol said (Kagolo, 8/27).

29 Aug 2009

Genvec to sell 8,000,000 shares to develop its TNFerade clinical program

GenVec, Inc. (Nasdaq: GNVC) announced today that it has entered into a purchase agreement with a single institutional investor for the sale of 8,000,000 shares of its common stock and warrants to purchase 4,000,000 shares of its common stock. The shares of common stock and warrants are being offered in units consisting of one share of common stock and 0.50 warrants to purchase one share of common stock at a price of $0.75 per unit. This represents a discount of approximately 8.3% to the closing price of GenVec common stock on August 26, 2009. The warrants have a term of five years and an exercise price of $0.828 per share.

28 Aug 2009

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Kenya on Thursday launched a national malaria campaign to encourage Kenyans to sleep under insecticide-treated nets (ITNs) every night to prevent infection, the Daily Nation reports.

28 Aug 2009

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

UPI reports on a recent review article in the journal PLoS Neglected Tropical Diseases that analyzed the toll of neglected tropical diseases on populations in sub-Saharan Africa. "Researchers said helminth (parasitic worm) infections account for approximately 85 percent of the neglected tropical diseases, which overall might be equivalent to more than double that caused by tuberculosis and as much as half of the area's malaria disease burden," the news service writes (8/26).

28 Aug 2009

Movember to present at the LIVESTRONG Global Cancer Summit

Staggering statistic: cancer kills more people every year than AIDS, tuberculosis and malaria combined. Joining more than 250 advocates from around the world, Adam Garone, co-founder and CEO of Movember, the world's largest charity for men's health, will present at the LIVESTRONG Global Cancer Summit in Dublin, Ireland, August 24 - 26.

27 Aug 2009

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

EDCTP welcomes project proposals as a response to the following calls: Tuberculosis vaccines, HIV/AIDS treatment and Member States Initiated projects.

27 Aug 2009

$201,339 grant offered to a professor for developing a database on enzyme functions

Since the advent of the Human Genome Project an explosion of data has sent the science world scrambling. There is a growing demand to fine-tune genomic codes, which list the "ingredients for life," but do not adequately explain how those ingredients function. A Rutgers University-Camden biochemist is addressing this knowledge gap through the creation of a database for quick "background checks" on all known enzyme functions. Thanks to a National Institute of Health grant, Peter Palenchar, an assistant professor of chemistry at Rutgers-Camden, will categorize decades-worth of scholarship on enzymes into a database, beginning with those that bind to molecules that contain adenosine.

27 Aug 2009

Aid agencies seek to access displaced Yemenis at 'high risk' of disease outbreaks

Aid agencies on Tuesday "appealed for better access" to "tens of thousands" of people in Yemen who have been displaced by violence and are facing "a high risk of outbreaks of malaria and diarrhoeal diseases among the already malnourished population," Reuters reports.

27 Aug 2009

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.

26 Aug 2009

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Guardian Technologies International, Inc. (OTCBB: GDTI) today announced that its Software Quality Assurance Team has completed all unit, component, integration, and systems tests of Signature Mapping TBDx™ (TBDx™) in preparation for September clinical trials in South Africa.

26 Aug 2009

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for serious chronic infections, announced today it has entered into a research collaboration agreement with the PATH Malaria Vaccine Initiative (MVI) to conduct proof-of-concept studies with its proprietary, recombinant vesicular stomatitis virus (rVSV) vector technology as a preventative malaria vaccine.

26 Aug 2009

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology.

25 Aug 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

A landmark report released today by the Lance Armstrong Foundation (LAF) estimates the total economic burden of new cancer cases at $305 billion in 2009. The findings are included in the report, "Breakaway: The Global Burden of Cancer - Challenges and Opportunities," released today in Dublin at the premiere LIVESTRONG Global Cancer Summit.

25 Aug 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers.

25 Aug 2009

Malaria News and Research

Latest Malaria News and Research

Yale University awarded $36 million ARRA funds for over 100 research projects

Antibiotic used to treat trachoma reduces child mortality in Ethiopia, study finds

World Climate Conference calls for global weather surveillance system, says could help predict disease outbreaks

Eye disease medication lowers death rate among Ethiopian children

Also in global health news: U.S. global development policy; DDT in Uganda; potential drought, famine in Ethiopia

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

Also in Global Health news: ARVs in Uganda; Brazil's fight against HIV/AIDS

Genvec to sell 8,000,000 shares to develop its TNFerade clinical program

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Also in global health news: NTD study; false cholera cases in Zimbabwe; contaminated water in Kenya; doctor's strike ends

Movember to present at the LIVESTRONG Global Cancer Summit

EDCTP welcomes proposals for tuberculosis vaccines and HIV/AIDS treatment projects

$201,339 grant offered to a professor for developing a database on enzyme functions

Aid agencies seek to access displaced Yemenis at 'high risk' of disease outbreaks

Avisio to acquire a portable sensory technology asset to instantly detect disease-causing pathogens

Quality test for Guardian Technologies International's Signature Mapping TBDx system completed

Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology

Genvec to use $2.5 million grant from NIAID for the development of novel cell lines

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Malaria News and Research

Latest Malaria News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in